- Home
- REPL vs MSIF Comparison
REPL vs MSIF Comparison
Compare REPL & MSIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- MSIF
- Stock Information
- Founded
- REPL 2015
- MSIF 2011
- Country
- REPL United States
- MSIF United States
- Employees
- REPL N/A
- MSIF N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- MSIF
- Sector
- REPL Health Care
- MSIF
- Exchange
- REPL Nasdaq
- MSIF NYSE
- Market Cap
- REPL 851.0M
- MSIF 791.6M
- IPO Year
- REPL 2018
- MSIF N/A
- Fundamental
- Price
- REPL $9.00
- MSIF $16.39
- Analyst Decision
- REPL Strong Buy
- MSIF Buy
- Analyst Count
- REPL 6
- MSIF 4
- Target Price
- REPL $20.00
- MSIF $18.75
- AVG Volume (30 Days)
- REPL 658.1K
- MSIF 84.8K
- Earning Date
- REPL 05-15-2025
- MSIF 01-01-0001
- Dividend Yield
- REPL N/A
- MSIF 15.14%
- EPS Growth
- REPL N/A
- MSIF N/A
- EPS
- REPL N/A
- MSIF 1.41
- Revenue
- REPL N/A
- MSIF $134,828,000.00
- Revenue This Year
- REPL $31.16
- MSIF N/A
- Revenue Next Year
- REPL N/A
- MSIF N/A
- P/E Ratio
- REPL N/A
- MSIF $11.82
- Revenue Growth
- REPL N/A
- MSIF 2.62
- 52 Week Low
- REPL $4.92
- MSIF $15.33
- 52 Week High
- REPL $17.00
- MSIF $18.00
- Technical
- Relative Strength Index (RSI)
- REPL 22.80
- MSIF N/A
- Support Level
- REPL $10.17
- MSIF N/A
- Resistance Level
- REPL $10.78
- MSIF N/A
- Average True Range (ATR)
- REPL 0.62
- MSIF 0.00
- MACD
- REPL -0.19
- MSIF 0.00
- Stochastic Oscillator
- REPL 0.00
- MSIF 0.00
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About MSIF MSC INCOME FUND INC
MSC Income Fund Inc is a non-diversified closed-end management investment company. The investment objective is to generate current income through debt and equity investments and the secondary objective is to generate long-term capital appreciation through such investments. The company invests in senior secured term loans, second lien loans, and mezzanine debt and selected equity investments issued by lower middle-market and middle-market companies.